OUR ANTIBIOTIC MANUFACTURING STANDARD

amr industry alliance

uniting to act on antimicrobial resistance
The AMR Industry Alliance is one of the largest private sector coalitions set up to provide sustainable solutions to curb antimicrobial resistance, with over 100 biotech, diagnostics, generics and research-based pharmaceutical companies and associations joining forces. read more

We drive and measure the life-sciences industry progress to curb antimicrobial resistance in four different areas:

Invest in R&D to meet public health needs with new innovative diagnostics & treatments
Improve access to high-quality antibiotics and ensuring that new ones are available to all
Work to reduce the development of antimicrobial resistance
Support measures to reduce environmental impact from production of antibiotics

shared goals

We are uniting efforts to reduce the development of antimicrobial resistance, invest in R&D to meet public health needs and improve access to antibiotics, vaccines and diagnostics.
find out more

progress report

Despite the ongoing challenges presented by the pandemic, the AMR Industry Alliance’s 2021 Progress Report captures efforts made by the life sciences industry to fight AMR across several domains: research and science, access, appropriate use, and manufacturing. The third iteration of this biannual report captures progress made by Alliance members between July 2019 and March 2021. Find out more below.
find out more

in action

Our case studies provide snap-shots from across the life-sciences industry, share information on the tangible steps we are taking to invest in new research to develop new antibiotics and vaccines, prevent infection, and improve appropriate use of antibiotics.
find out more

latest news

13/06/2022

AMR Industry Alliance Launches Antibiotic Manufacturing Standard to Help Mitigate the Impacts of Antimicrobial Resistance

Standard provides guidance, calls on manufacturers to improve waste management programs. Geneva – June 14, 2022 – The AMR Industry Alliance, the largest life-sciences coalition set up to provide...

Read more
06/04/2022

2022 Stewardship Prize: Now Accepting Submissions

    While significant efforts have been initiated across low- and middle-income countries (LMICs) to address AMR stewardship and appropriate use of antibiotics, limited resources exist...

Read more
23/11/2021

Stewardship Prize Winner Announced

Prize Winner: Infectious Diseases Institute - Kampala, Uganda After careful review, the AMR Industry Alliance is proud to announce the Infectious Diseases Institute (IDI) in Kampala, Uganda as the...

Read more
view all

amr in numbers

AMR Impact

Life-sciences at the forefront of the battle against AMR

Development of National Action Plans

R&D

Biotechs

Diagnostics

from the blog

Posted on 18/11/2020
By Dr Ron Daniels

Antimicrobial Resistance and the Burden of Sepsis

Sepsis is a devastating condition resulting from a dysregulated immune system response to infection, which can lead to organ failure and death. Each year, sepsis affects close to 50 million people globally, of whom more than 40% are children under age 5 particularly in low- and middle-income countri...

Read more view all
Biovertis AG, Austria